By: Andrew Serwin, Kristi Kung, Bethany J. Hills, Christine Lentz
With the mounting mental health crisis intensified by the COVID-19 pandemic, the telemental health industry has exploded in recent years. According to
Continue Reading Guest blog: California expands scope of Confidentiality of Medical Information Act, strengthening protections for mental health information exchanged through digital health applications
By: Louann Fang Richard, Brent L. Bernell, Andrew D. Ledbetter, Eric Forni, Rita M. Patel, Keith Ranta, Bryan Card
The Securities and Exchange Commission (SEC) has approved, by a
Continue Reading Guest blog: SEC adopts final rules for clawback of erroneously awarded compensation
By: Jim Greenwood, Alex Pinson, Jamie Gregorian
The Inflation Reduction Act (IRA) significantly impacts the US economic model for prescription drug innovation through the imposition of mandatory negotiations in which federal officials set
Continue Reading Guest Blog: The potential for unintended consequences in the Inflation Reduction Act
By: Stefanie Jill Fogel, Angela C. Agrusa, Maggie Craig, Amy Pressman
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
Topics in
Continue Reading Food and Beverage News and Trends
By: Christine Daya, Nicholas Klein, Sarah E. Kahn, Karla Cure, Matthew Larson
On October 20, 2022, the US Department of the Treasury released the Committee on Foreign Investment in the United
Continue Reading Guest Blog: New CFIUS Enforcement and Penalty Guidelines signal increased focus on enforcement
The DLA Piper Life Sciences sector team are delighted to announce the launch of our new Cross-border Guide to Clinical Trials and Privacy.
This Guide – created by privacy professionals from our global Life
Continue Reading Privacy requirements for clinical trials: a cross-border guide
The Directors of the UK Office of Financial Sanctions Implementation (OFSI) and the US Office of Foreign Assets Control (OFAC), Giles Thomson and Andrea Gacki, have announced, via a joint press statement1, the
Continue Reading Enhancing the US-UK Sanctions Partnership
Even before the pandemic, businesses have been facing new challenges in disputes – not just the extent of disputes, but their very nature.
DLA Piper’s first annual Product Liability Symposium, hosted by our Product Liability Diversity
Continue Reading Fortifying ourselves for 2023: Six key takeaways from DLA Piper’s D&I Product Liability Symposium
For the latest DLA Piper report on hydrogen, we partnered with Reuters to cover the conclusions of the Reuters Hydrogen 2022 conference. Clean hydrogen is widely regarded as a key component in achieving a sustainable
Continue Reading Report: Hydrogen 2022 – Tracking progress towards a clean hydrogen economy
In a recent speech, Deputy Attorney General (DAG) Lisa Monaco unveiled the Department of Justice’s top priorities for corporate criminal enforcement. The speech corresponded with the release of a memorandum (which has popularly been dubbed
Continue Reading Aligning your compliance program with the new DOJ guidance on corporate criminal enforcement: 3 takeaways and 4 practical steps
